Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Perstorp Belgium

6 Mar 2017 07:02

RNS Number : 5461Y
Synthomer PLC
06 March 2017
 

The Company considers this announcement to contain inside information

 

6 March 2017

Synthomer plc

Acquisition of Perstorp Oxo Belgium AB

 

Synthomer plc (LSE:SYNT) ('Synthomer' or the 'Group'), a leading speciality chemicals company, today announces the acquisition of Perstorp Oxo Belgium AB ('Perstorp Belgium') from The Perstorp Group, a speciality chemicals innovator and supplier based in Sweden.

 

Synthomer will pay an enterprise value of €78 million which will be fully funded from existing financial resources. The acquisition, which completed on 5 March, represents a multiple of 8.5x 2016 Adjusted EBITDA(1). This is expected to fall to approximately 7.0x EBITDA post integration reflecting operational efficiencies and increased volumes to existing customers. Perstorp Belgium will be consolidated into Synthomer's results from March 2017.

 

In the year to 31 December 2016, Perstorp Belgium generated reported earnings before interest and tax of €8 million. At 31 December 2016, Perstorp Belgium had gross assets of €21 million.

 

Perstorp Belgium is a niche performance additives business serving the decorative and industrial coatings industries. It has strong market leadership positions (#1 or #2) and serves a highly attractive, blue-chip customer base. The business operates from a well located, single site in Ghent, Belgium where there is potential for growth capacity for future demand.

 

Perstorp Belgium is highly complementary to Synthomer's existing markets and customers. The Group will focus on expanding Perstorp Belgium's market position by developing closer relationships with customers through leveraging its existing sales and technical services infrastructure, and driving operational performance.

 

Calum MacLean, Chief Executive Officer of Synthomer, commented:

"The acquisition of Perstorp Belgium represents another step forward in our strategy to continue to grow and develop Synthomer. The business is an excellent fit and provides increased access to new products and customers. We look forward to welcoming our new colleagues and integrating the business with Synthomer through the remainder of this year."

 

Note 1 - Reported EBITDA of €8.8m excluding certain Perstorp Group overhead cost allocations of €0.3m resulting in Adjusted EBITDA of €9.1m

 

-Ends-

Enquiries:

Calum MacLean, Chief Executive Officer

Tel: 01279 436211

Stephen Bennett, Chief Financial Officer

Tel: 01279 436211

Charles Armitstead, Teneo Blue Rubicon

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFIDVRIEIID
Date   Source Headline
16th May 20137:00 amRNSInterim Management Statement
2nd May 20134:59 pmRNSHolding(s) in Company
24th Apr 20134:37 pmRNSDirector/PDMR Shareholding
24th Apr 20134:36 pmRNSDirector/PDMR Shareholding
24th Apr 201311:14 amRNSHolding(s) in Company
16th Apr 201311:52 amRNSReplacement Annual Financial Report
16th Apr 20139:29 amRNSAnnual Financial Report
15th Apr 20131:58 pmRNSHolding(s) in Company
9th Apr 201311:52 amRNSDirector/PDMR Shareholding
28th Mar 20139:19 amRNSHolding(s) in Company
19th Mar 20134:31 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSPreliminary Results
14th Feb 20131:59 pmRNSReplacement Director Declaration
14th Feb 20131:00 pmRNSDirectorate Change
13th Feb 201311:23 amRNSHolding(s) in Company
7th Feb 201312:26 pmRNSDirectorate Change
1st Feb 20134:37 pmRNSDirector Declaration
19th Dec 201210:08 amRNSReplacement Holding(s) in Company
17th Dec 201210:11 amRNSDirector Declaration
14th Dec 201212:38 pmRNSReplacement Holding(s) in Company
14th Dec 201212:27 pmRNSDirector Declaration
6th Dec 20124:35 pmRNSHolding(s) in Company
4th Dec 201212:17 pmRNSResult of EGM
16th Nov 201211:34 amRNSDirector Declaration
8th Nov 20127:00 amRNSNotice of General Meeting
8th Nov 20127:00 amRNSInterim Management Statement
1st Nov 201212:28 pmRNSHolding(s) in Company
12th Oct 20124:15 pmRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirectorate Change
27th Sep 20122:24 pmRNSHolding(s) in Company
25th Sep 20124:06 pmRNSHolding(s) in Company
10th Sep 20123:38 pmRNSDirector Declaration
6th Sep 20128:58 amRNSHolding(s) in Company
28th Aug 20127:00 amRNSInterim Results 2012
22nd Aug 20125:06 pmRNSHolding(s) in Company
13th Aug 20124:32 pmRNSHolding(s) in Company
24th Jul 201210:23 amRNSHolding(s) in Company
20th Jul 20124:10 pmRNSHolding(s) in Company
16th Jul 20129:33 amRNSHolding(s) in Company
13th Jul 201210:38 amRNSChange of Auditor
6th Jul 20129:38 amRNSHolding(s) in Company
3rd Jul 20124:35 pmRNSHolding(s) in Company
2nd Jul 201212:46 pmRNSHolding(s) in Company
2nd Jul 201211:11 amRNSDirector/PDMR Shareholding
27th Jun 20127:00 amRNSTrading Statement
12th Jun 201210:30 amRNSDirector/PDMR Shareholding
8th Jun 20122:09 pmRNSDirector/PDMR Shareholding
7th Jun 20124:35 pmRNSDirector/PDMR Shareholding
25th May 201211:00 amRNSDirector Declaration
17th May 201212:22 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.